Open Collections

UBC Faculty Research and Publications

Economic burden of asthma: a systematic review Bahadori, Katayoun; Doyle-Waters, Mary M.; Marra, Carlo A.; Lynd, Larry; Alasaly, Kadria; Swiston, John; FitzGerald, J. M.

Abstract

Background: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma. Methods: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008. Results: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity. Conclusion: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.

Item Metadata

Title
Economic burden of asthma: a systematic review
Creator
Bahadori, Katayoun; Doyle-Waters, Mary M.; Marra, Carlo A.; Lynd, Larry; Alasaly, Kadria; Swiston, John; FitzGerald, J. M.
Contributor
Centre for Clinical Epidemiology and Evaluation
Publisher
BioMed Central
Date Issued
2009-05-19
Description
Background: Asthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma. Methods: We performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008. Results: Sixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity. Conclusion: Despite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma.
Genre
Article
Type
Text
Language
eng
Date Available
2016-01-26
Provider
Vancouver : University of British Columbia Library
Rights
Attribution 4.0 International (CC BY 4.0)
DOI
10.14288/1.0223779
URI
http://hdl.handle.net/2429/56725
Affiliation
Medicine, Department of; Pharmaceutical Sciences, Faculty of; Population and Public Health (SPPH), School of; Non UBC; Medicine, Faculty of
Citation
BMC Pulmonary Medicine. 2009 May 19;9(1):24
Publisher DOI
10.1186/1471-2466-9-24
Peer Review Status
Reviewed
Scholarly Level
Faculty
Copyright Holder
Bahadori et al.
Rights URI
http://creativecommons.org/licenses/by/4.0/
Aggregated Source Repository
DSpace

Item Media

Item Citations and Data

Rights

Attribution 4.0 International (CC BY 4.0)